317358-76-2

Basic information

• Product Name: 4-(benzyloxy)-3-bromobenzonitrile
• Synonyms: 4-(benzyloxy)-3-bromobenzonitrile
• CAS NO: 317358-76-2
• Molecular Weight: 288.143
• Mol File: 317358-76-2.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 4-(benzyloxy)-3-bromobenzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(benzyloxy)-3-bromobenzonitrile(317358-76-2)
• EPA Substance Registry System: 4-(benzyloxy)-3-bromobenzonitrile(317358-76-2)

Safety Data

• Hazardous Substances Data: 317358-76-2(Hazardous Substances Data)

Upstream product

• 100-39-0 benzyl bromide 
• 69455-12-5 4-benzyloxy-3-bromobenzaldehyde 
• 2973-78-6 3-bromo-4-hydroxybenzylaldehyde 
• 2315-86-8 3-bromo-4-hydroxybenzonitrile 
• 100-44-7 benzyl chloride 

Downstream Products

• 1311138-63-2 3-ethyl-4-[(phenylmethyl)oxy]benzonitrile 
• 4997-55-1 3-ethyl-4-hydroxy-benzonitrile 
• 1311137-16-2 4-{[5-(4,4-dimethyl-2,5-dioxo-1-imidazolidinyl)-2-pyridinyl]oxy}-3-ethylbenzonitrile 
• 1134197-88-8 3-{[1-(trans-1-methyl-4-{[2-(methyloxy)ethyl]oxy}cyclohexyl)-4-piperidinyl]amino}-4-[(phenylmethyl)oxy]benzonitrile 

Relevant articles and documents

Synthesis of benzyloxycyanophenylboronic esters

The synthesis of six new benzyloxycyanoboronic esters: 2-benzyloxy-6- cyanophenyl-4,4,5,5-tetramethyl-[1,3,2]-dioxaborolane (4a), 4-benzyloxy-2- cyanophenyl-4,4,5, 5-tetramethyl-[1,3,2]dioxaborolane (4b), 4-benzyloxy-3- cyanophenyl-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (8a), 2-benzyloxy-5- cyanophenyl-4,4,5,5-tetramethyl-[1,3,2]-dioxaborolane (8b), 3-benzyloxy-4- cyanophenyl-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (12a), and 2-benzyloxy-5-cyanophenyl-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (12b) is reported. Copyright by Walter de Gruyter Berlin Boston.

CONDENSED HETEROCYCLIC COMPOUND

The present invention relates to a condensed heterocyclic compound that has an enteropeptidase inhibitory effect and is useful in the treatment or prevention of obesity, diabetes mellitus, or the like, and a medicament containing the same. Specifically, t

COMPOUNDS WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE

Compounds of formula (I) or a salt thereof are provided: wherein R4, R5, R6, Q, A, Y and R are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments for treating psychotic disorders, cognitive impairments and Alzheimer's Disease are disclosed. The invention further discloses pharmaceutical compositions comprising the compounds.